Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Here comes the selling pressure these license announcements bring.

Oct 03, 2008 06:11AM

As I recall ES was supposed to have been finished selling about 2 months ago. Did he buy more shares to unload? Was he really not finished because, even though some here said he was deplete of shares, he really still had shares to sell?

My questions: how many shares did ES have and how many does he have left? Did he get more shares along the way? Is he still capable of getting more shares ( from warrants or ? ) If anyone can answer one or all of these the picture might be a lot clearer. Thanks in advance.

Share
New Message
Please login to post a reply